Literature DB >> 11606830

A comparative study of the postoperative allogeneic blood-sparing effects of tranexamic acid and of desmopressin after total knee replacement.

E Zohar1, B Fredman, M H Ellis, N Ifrach, A Stern, R Jedeikin.   

Abstract

BACKGROUND: Tissue hypoxia and reperfusion induce abnormal hemostatic function. Therefore, bleeding after total knee replacement (TKR) may be a result of a tourniquet-induced imbalance of the procoagulant and fibrinolytic systems. Because laboratory confirmation of tourniquet-induced abnormal hemostasis is difficult to obtain, indirect evidence must be sought. STUDY DESIGN AND METHODS: A prospective, single-blind study of 40 patients undergoing TKR was performed. In the tranexamic acid (TA) group, in the 30 minutes before the limb tourniquet was deflated, an IV bolus dose of TA (15 mg/kg) was administered. Thereafter, a constant IV infusion of 10 mg per kg per hour was administered until 12 hours after tourniquet deflation. In the desmopressin group, desmopressin (0.3 mg/kg) and saline were administered by a similar protocol. No blood was administered intraoperatively. A postoperative Hct <27 percent constituted the postoperative transfusion trigger. Patients were examined daily for signs of lower-limb deep vein thrombosis, and they underwent lower-limb Doppler ultrasound on postoperative Day 5. Three months after surgery, the incidence of delayed thromboembolic events was assessed.
RESULTS: During the first 12 postoperative hours, blood accumulation in the surgical drain was significantly (p<0.05) lower in the TA group (162 mL +/- 129) than in the desmopressin group (342 mL +/- 169). From the sixth postoperative hour until 3 days postoperatively, Hct levels were significantly lower in the desmopressin group than in the TA group. Significantly more allogeneic blood was transfused in the desmopressin group (11 patients received 16 units) than in the TA group (3 patients each received 1 unit) (p<0.02). There were no clinical signs of deep vein thrombosis or abnormal Doppler ultrasound studies. Three months postoperatively, there were no thromboembolic events among the 37 patients interviewed.
CONCLUSION: TA induces better blood sparing than desmopressin. Therefore, a tourniquet-induced increase in fibrinolysis is the likely cause of delayed bleeding after TKR surgery. However, before routine administration, the effect of TA on the incidence of thromboembolic events requires further investigation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11606830     DOI: 10.1046/j.1537-2995.2001.41101285.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  6 in total

1.  Low risk of thromboembolic complications with tranexamic acid after primary total hip and knee arthroplasty.

Authors:  Blake P Gillette; Lori J DeSimone; Robert T Trousdale; Mark W Pagnano; Rafael J Sierra
Journal:  Clin Orthop Relat Res       Date:  2013-01       Impact factor: 4.176

Review 2.  Pharmacological strategies to decrease transfusion requirements in patients undergoing surgery.

Authors:  Robert J Porte; Frank W G Leebeek
Journal:  Drugs       Date:  2002       Impact factor: 9.546

3.  Post-operative blood loss in total knee arthroplasty: knee flexion versus pharmacological techniques.

Authors:  Pierluigi Antinolfi; Bernardo Innocenti; Auro Caraffa; Giuseppe Peretti; Giuliano Cerulli
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2013-09-29       Impact factor: 4.342

4.  Preliminary results suggest tranexamic acid is safe and effective in arthroplasty patients with severe comorbidities.

Authors:  Daniel R Whiting; Blake P Gillette; Christopher Duncan; Hugh Smith; Mark W Pagnano; Rafael J Sierra
Journal:  Clin Orthop Relat Res       Date:  2014-01       Impact factor: 4.176

Review 5.  Desmopressin use for minimising perioperative blood transfusion.

Authors:  Michael J Desborough; Kathryn Oakland; Charlotte Brierley; Sean Bennett; Carolyn Doree; Marialena Trivella; Sally Hopewell; Simon J Stanworth; Lise J Estcourt
Journal:  Cochrane Database Syst Rev       Date:  2017-07-10

6.  Selection of the optimal dosage of tranexamic acid to reduce blood loss during pediatric cleft palate surgery.

Authors:  Amir Shafa; Hamidreza Shetabi; Lili Adineh-Mehr; Keivan Bahrami
Journal:  Tzu Chi Med J       Date:  2020-10-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.